Skip survey header

Fentanyl Test Strip Direct Program Application, F-03119 (01/2023)

Part 1: Program Overview

The Fentanyl Test Strip Direct Program is a partnership between the Wisconsin Department of Health Services (DHS) and MicroDistributing, a manufacturer of fentanyl test strips. The goal is to reduce opioid-related deaths by providing free fentanyl test strips to people at risk for an opioid overdose through participating agencies serving communities throughout Wisconsin. Agencies participating in the Fentanyl Test Strip Direct Program receive fentanyl test strips at no cost to distribute to people they serve.

Fentanyl test strips are used to determine whether there is fentanyl present in a drug so people who use drugs can make informed decisions about their drug supply. 

Agencies must review and accept the information on this page and complete the application on the following page to participate in the Fentanyl Test Direct Program.

Eligible applicants

The following agencies may apply at this time to participate in the Fentanyl Test Strip Direct Program.
  • County or municipal public health departments (or their designee)
  • Tribal health clinics (or their designee)
  • Syringe access programs
  • Opioid treatment programs (Program certified under Wis. Admin. Code § DHS 75.15)
Requirements

All agencies participating in the Fentanyl Test Strip Direct Program must: 
  • Have at least one staff member attend a DHS sponsored fentanyl test strip train-the-trainer event. Information about these events is posted on the DHS website
  • Train people at risk of an opioid-related overdose on how to use fentanyl test strips and distribute fentanyl test strips to them following the training session.
  • Establish a tracking system to document fentanyl test strip training and distribution.    
  • Complete data reporting of training and distribution efforts including: 
    • Number of trainings held monthly.
    • Number of individuals trained by sector monthly.
    • Number of fentanyl test strip trainers trained monthly.
    • Number of fentanyl test strips distributed monthly.
    • Information on the fentanyl test strips were used in the community, including:
      • Type of drug tested
      • Test result: positive or negative for fentanyl
      • If the test result was positive, did the person: 
        • Make a change with usual use?
        • Throw out the drug?
        • Confirm availability of naloxone?
        • Change route of administration?
        • Space out doses?
        • Use less to test potency?
        • Use with someone else or call Never Use Alone?
        • Share the test results with others?
Agencies accepted into the program will be notified by the Division of Care and Treatment Services. This notification will include the number of fentanyl test strips that will be available to the agency for the year, instructions for requesting the fentanyl test strips, and instructions on how to report information regarding training and distribution efforts.

Accepted agencies order fentanyl test strips through the Division of Care and Treatment Services for direct shipment to their agency. Agencies can order fentanyl test strips by the box as they need it throughout year, up to the agency's approved amount. Each box of fentanyl test strips contains 100 individually packaged test strips. Bundles of four fentanyl test strips can be provided to each client. Orders typically are shipped within 48 hours of receipt. 

There is no limit to the amount of fentanyl test strips an agency can request through the application process. Applicants should identify their anticipated annual need based on their best estimates, prior experience, and community need. Awards will be made based on available funding and the local overdose data.
 
Please indicate that you have reviewed the information on this page.